应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
WXIBF Wuxi Biologics (Cayman) Inc
盘前交易 07-14 16:00:00 EDT 延时
资讯
新帖
简况
药明生物7月10日成交额为129.00美元
市场透视 · 07-11
药明生物7月10日成交额为129.00美元
药明生物取得评估抗原沉默效应对抗体药效影响方法及应用专利
金融界 · 07-11
药明生物取得评估抗原沉默效应对抗体药效影响方法及应用专利
药明生物7月9日成交额为1394.00美元
市场透视 · 07-10
药明生物7月9日成交额为1394.00美元
生物药产业合力突围:一款新型长效激素的本土化落地样本
E药经理人 · 07-04
生物药产业合力突围:一款新型长效激素的本土化落地样本
加载更多
公司概况
公司名称:
Wuxi Biologics (Cayman) Inc
所属市场:
PINK LIMITED
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"WXIBF","market":"US","secType":"STK","nameCN":"Wuxi Biologics (Cayman) Inc","latestPrice":3.22,"timestamp":1752523200000,"preClose":3.22,"halted":0,"volume":0,"delay":15,"floatShares":3505111406,"shares":4104593915,"eps":0.107499,"marketStatus":"盘前交易","change":0,"latestTime":"07-14 16:00:00 EDT 延时","open":3.22,"high":3.22,"low":3.22,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.107499,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752586200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":3.22,"volumeRatio":0.0015352375319682174},"requestUrl":"/m/hq/s/WXIBF","defaultTab":"news","newsList":[{"id":"2550939897","title":"药明生物7月10日成交额为129.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550939897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550939897?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:19","pubTimestamp":1752221958,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日,药明生物成交额为129.00美元,成交额较昨日减少90.75%,当日成交量为40.00股。药明生物于2025年7月10日涨0.0%,报3.22美元,该股过去5个交易日涨1.26%,年初至今涨48.39%,过去60日涨33.06%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171519a6a37751&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171519a6a37751&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXIBF"],"gpt_icon":0},{"id":"2550608193","title":"药明生物取得评估抗原沉默效应对抗体药效影响方法及应用专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2550608193","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550608193?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:13","pubTimestamp":1752196404,"startTime":"0","endTime":"0","summary":"金融界2025年7月11日消息,国家知识产权局信息显示,上海药明生物技术有限公司取得一项名为“一种评估抗原沉默效应对抗体药效影响的方法及其应用”的专利,授权公告号CN114371282B,申请日期为2021年12月。天眼查资料显示,上海药明生物技术有限公司,成立于2015年,位于上海市,是一家以从事研究和试验发展为主的企业。企业注册资本133000万人民币。通过天眼查大数据分析,上海药明生物技术有限公司共对外投资了1家企业,参与招投标项目12次,财产线索方面有商标信息92条,专利信息234条,此外企业还拥有行政许可187个。本文源自:金融界作者:情报员","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091605a4438947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091605a4438947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516422366.SGD","LU0417516902.SGD","WXIBF","BK1141","LU1794554557.SGD","SG9999002463.SGD","LU0516422952.EUR","LU0359202008.SGD","LU0588546209.SGD","LU1242518931.SGD","LU0359201612.USD","BK1521","LU0572944931.SGD","LU0516423174.USD","IE00B0JY6N72.USD","LU0348735423.USD","LU0326950275.SGD","LU1688375341.USD","LU0456827905.SGD","02269","LU1880383366.USD","LU0320764599.SGD","LU0043850808.USD","LU0039217434.USD","LU0516423091.SGD","LU0327786744.USD","LU0819121731.USD","LU0417516738.SGD","LU0823426308.USD","LU0856984785.SGD","LU2039709279.SGD","LU0516422440.USD","LU0348825331.USD","LU0456846285.SGD","LU1720050803.USD","LU0979878070.USD","BK1576","BK1589","SG9999002562.SGD","LU0181495838.USD","LU0307460666.USD","BK1610","LU0823426480.USD","LU0051755006.USD","LU1242518857.USD","LU0052750758.USD","LU0140636845.USD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2550612648","title":"药明生物7月9日成交额为1394.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550612648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550612648?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:13","pubTimestamp":1752135185,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日,药明生物成交额为1394.00美元,当日成交量为433.00股。药明生物于2025年7月9日涨1.26%,报3.22美元,该股过去5个交易日涨1.26%,年初至今涨48.39%,过去60日涨33.06%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710164640a44229fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710164640a44229fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXIBF"],"gpt_icon":0},{"id":"2548513398","title":"生物药产业合力突围:一款新型长效激素的本土化落地样本","url":"https://stock-news.laohu8.com/highlight/detail?id=2548513398","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548513398?lang=zh_cn&edition=full","pubTime":"2025-07-04 18:28","pubTimestamp":1751624921,"startTime":"0","endTime":"0","summary":"在生物药管线冲刺迈入“兑现期”前,如何将高技术壁垒的创新药物真正推向商业化,成为Biotech绕不开的现实大考。但当一部分Biotech挺进临床三期,站到商业化门槛时,一个现实的问题横亘在眼前:如何将创新项目合规、高效、高质量地推向规模化生产,完成从概念验证到商业化落地的完美闭环。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704183403a436c685&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704183403a436c685&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516422366.SGD","LU0417516902.SGD","WXIBF","BK1141","LU1794554557.SGD","SG9999002463.SGD","LU0516422952.EUR","LU0359202008.SGD","LU0588546209.SGD","LU1242518931.SGD","LU0359201612.USD","BK1521","LU0572944931.SGD","LU0516423174.USD","IE00B0JY6N72.USD","LU0348735423.USD","LU0326950275.SGD","LU1688375341.USD","LU0456827905.SGD","02269","LU1880383366.USD","02561","LU0320764599.SGD","LU0043850808.USD","LU0039217434.USD","LU0516423091.SGD","LU0327786744.USD","LU0819121731.USD","LU0417516738.SGD","LU0823426308.USD","LU0856984785.SGD","LU2039709279.SGD","LU0516422440.USD","LU0348825331.USD","LU0456846285.SGD","LU1720050803.USD","LU0979878070.USD","BK1576","BK1589","SG9999002562.SGD","LU0181495838.USD","LU0307460666.USD","BK1610","LU0823426480.USD","LU0051755006.USD","LU1242518857.USD","LU0052750758.USD","LU0140636845.USD","LU0708995583.HKD"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.1576},{"period":"6month","weight":-0.0314},{"period":"1year","weight":0.3021},{"period":"ytd","weight":0.6619}],"exchange":"PINK LIMITED","name":"Wuxi Biologics (Cayman) Inc","nameEN":"Wuxi Biologics (Cayman) Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Wuxi Biologics (Cayman) Inc(WXIBF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Wuxi Biologics (Cayman) Inc(WXIBF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Wuxi Biologics (Cayman) Inc,WXIBF,Wuxi Biologics (Cayman) Inc股票,Wuxi Biologics (Cayman) Inc股票老虎,Wuxi Biologics (Cayman) Inc股票老虎国际,Wuxi Biologics (Cayman) Inc行情,Wuxi Biologics (Cayman) Inc股票行情,Wuxi Biologics (Cayman) Inc股价,Wuxi Biologics (Cayman) Inc股市,Wuxi Biologics (Cayman) Inc股票价格,Wuxi Biologics (Cayman) Inc股票交易,Wuxi Biologics (Cayman) Inc股票购买,Wuxi Biologics (Cayman) Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Wuxi Biologics (Cayman) Inc(WXIBF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Wuxi Biologics (Cayman) Inc(WXIBF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}